» Articles » PMID: 30245736

A Quantitative Performance Study of Two Automatic Methods for the Diagnosis of Ovarian Cancer

Overview
Publisher Elsevier
Date 2018 Sep 25
PMID 30245736
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

We present a quantitative study of the performance of two automatic methods for the early detection of ovarian cancer that can exploit longitudinal measurements of multiple biomarkers. The study is carried out for a subset of the data collected in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). We use statistical analysis techniques, such as the area under the Receiver Operating Characteristic (ROC) curve, for evaluating the performance of two techniques that aim at the classification of subjects as either healthy or suffering from the disease using time-series of multiple biomarkers as inputs. The first method relies on a Bayesian hierarchical model that establishes connections within a set of clinically interpretable parameters. The second technique is a purely discriminative method that employs a recurrent neural network (RNN) for the binary classification of the inputs. For the available dataset, the performance of the two detection schemes is similar (the area under ROC curve is 0.98 for the combination of three biomarkers) and the Bayesian approach has the advantage that its outputs (parameters estimates and their uncertainty) can be further analysed by a clinical expert.

Citing Articles

Advancing Precision Oncology Through Modeling of Longitudinal and Multimodal Data.

Zhuang L, Park S, Skates S, Prosper A, Aberle D, Hsu W ArXiv. 2025; .

PMID: 39990791 PMC: 11844620.


Novel efficient reservoir computing methodologies for regular and irregular time series classification.

Li Z, Andreev A, Hramov A, Blyuss O, Zaikin A Nonlinear Dyn. 2025; 113(5):4045-4062.

PMID: 39822383 PMC: 11732944. DOI: 10.1007/s11071-024-10244-3.


Intelligent system based on multiple networks for accurate ovarian tumor semantic segmentation.

El-Khatib M, Popescu D, Teodor O, Ichim L Heliyon. 2024; 10(17):e37386.

PMID: 39296061 PMC: 11409139. DOI: 10.1016/j.heliyon.2024.e37386.


Preoperative Molecular Subtype Classification Prediction of Ovarian Cancer Based on Multi-Parametric Magnetic Resonance Imaging Multi-Sequence Feature Fusion Network.

Du Y, Wang T, Qu L, Li H, Guo Q, Wang H Bioengineering (Basel). 2024; 11(5).

PMID: 38790338 PMC: 11117786. DOI: 10.3390/bioengineering11050472.


Bayesian and deep-learning models applied to the early detection of ovarian cancer using multiple longitudinal biomarkers.

Abrego L, Zaikin A, Marino I, Krivonosov M, Jacobs I, Menon U Cancer Med. 2024; 13(7):e7163.

PMID: 38597129 PMC: 11004913. DOI: 10.1002/cam4.7163.


References
1.
Buys S, Partridge E, Black A, Johnson C, Lamerato L, Isaacs C . Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA. 2011; 305(22):2295-303. DOI: 10.1001/jama.2011.766. View

2.
Cramer D, Bast Jr R, Berg C, Diamandis E, Godwin A, Hartge P . Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens. Cancer Prev Res (Phila). 2011; 4(3):365-74. PMC: 3085251. DOI: 10.1158/1940-6207.CAPR-10-0195. View

3.
Montagnana M, Danese E, Ruzzenente O, Bresciani V, Nuzzo T, Gelati M . The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?. Clin Chem Lab Med. 2011; 49(3):521-5. DOI: 10.1515/CCLM.2011.075. View

4.
Havrilesky L, Whitehead C, Rubatt J, Cheek R, Groelke J, He Q . Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence. Gynecol Oncol. 2008; 110(3):374-82. DOI: 10.1016/j.ygyno.2008.04.041. View

5.
Jacobs I, Menon U . Progress and challenges in screening for early detection of ovarian cancer. Mol Cell Proteomics. 2004; 3(4):355-66. DOI: 10.1074/mcp.R400006-MCP200. View